DJIA 16,374.76 23.38 0.14%
NASDAQ 4,733.50 -16.48 -0.35%
S&P 500 1,951.13 2.27 0.12%
market minute promo

BioTime, Inc. (NYSEMKT: BTX)

2.98 -0.13 (-4.18%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BTX $2.98 -4.18%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.08
Previous Close $3.11
Daily Range $2.92 - $3.12
52-Week Range $2.20 - $5.95
Market Cap $248.2M
P/E Ratio -6.10
Dividend (Yield) $0.00 (0.0%)
Volume 129,195
Average Daily Volume 232,763
Current FY EPS $0.00

Sector

Healthcare

Industry

Drug Makers

BioTime, Inc. (BTX) Description

BioTime Inc. is engaged in the business of developing blood plasma volume expanders and related products and stem cell related products and technology for diagnostic therapeutic and research use. Website: http://www.biotimeinc.com/

News & Commentary

The Small-Cap Stock I'm Watching in 2015

Three Motley Fools tell investors which small-cap stocks they'll be watching in 2015.

Insider Trading Alert - ASYS, BTX And STAG Traded By Insiders

A Case For Ocata Therapeutics

BioTime's Prospectus Setting Up Potential Divestiture Of Asterias Becomes Effective

Asterias Biotherapeutics' Stem Cell Program Is Dead On Arrival

BioTime's Clinical Grade Stem Cells From Subsidiary ES Cell International to Be Used in Planned CIRM

BioTime's Clinical Grade Stem Cells From Subsidiary ES Cell International to Be Used in Planned CIRM-Funded Preclinical Studies of Huntington's Disease

Thursday Sector Leaders: Biotechnology, Drugs

How Apple ResearchKit Could Change Science Forever

Asterias Biotherapeutics Announces Public Offering of Common Stock

BioTime, Inc.: Following The Smart Money

See More BTX News...

BTX's Top Competitors

BTX $2.98 (-4.18%)
Current stock: BTX
AMGN $149.23 (-2.01%)
Current stock: AMGN
GILD $101.91 (-2.26%)
Current stock: GILD
BIIB $301.63 (-0.85%)
Current stock: BIIB